Magazine: A choppy history of racial bias in oximetry
In this issue: Covid-19 has put bias in oximetry back in the spotlight, DCTs are helping break down barriers in women's health trials, continuous flow manufacturing…
By
Kezia Parkins is the lead editor for Medical Device Network and Medical Technology Magazine. She is an experienced healthcare writer and editor with special interests in MedTech, clinical trials, patient centricity and global health equality.
In this issue: Covid-19 has put bias in oximetry back in the spotlight, DCTs are helping break down barriers in women's health trials, continuous flow manufacturing…
By Kezia ParkinsLumiraDx and digital health company Audere have collaborated to provide a self-collected Covid-19 nasal sample collection kit intended for…
By Kezia ParkinsThe US Food and Drug Administration (FDA) has granted clearance to the Investigational New Drug (IND) application of Tonix…
By Kezia ParkinsFrench company Eurobio Scientific has obtained CE mark for its test EBX 047, Eurobioplex SARS-CoV-2 Fast-SVD – Screening and…
By Kezia ParkinsEurofins Scientific has signed a share purchase agreement with Transgenic to acquire molecular biology-based testing provider Genetic Lab (G…
By Kezia ParkinsThe US Food and Drug Administration (FDA) has amended the initial Emergency Use Authorization (EUA) of GenBody America’s Covid-19…
By Kezia ParkinsHealthTrackRx has reported that its polymerase chain reaction (PCR) testing technology can identify the SARS-CoV-2 virus with the Omicron…
By Kezia ParkinsFluidigm has reported that its Fluidigm Advanta Dx SARS-CoV-2 RT-PCR Assay can detect the Omicron variant of SARS-CoV-2. The…
By Kezia ParkinsBioGX has reported that its portfolio of Covid-19 tests that work on the nucleocapsid (N-gene) and envelope (E-gene) can…
By Kezia ParkinsThank you for subscribing to Medical Device Network